#Lenacapavir is a twice-yearly injectable option for HIV prevention.
Its rollout marks a significant milestone in South Africa's ongoing efforts to combat HIV/AIDS and underscores the strong collaboration between government, civil society, the private sector, and development partners committed to ending HIV as a public health threat in the country.